Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

283
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
283
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

70.1K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.1K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

162
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
162
Antibiotic Selection00:57

Antibiotic Selection

52.1K
Overview
52.1K
Infection01:20

Infection

7.0K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention of Surgical Site Contamination With Cutibacterium acnes During Cardiac Surgery: A Randomized Clinical Trial.

JAMA network open·2026
Same author

Report on Brachystomatidae and Empididae (Hemerodromiinae, Clinocerinae) from continental Portugal and neighbouring countries.

Zootaxa·2026
Same author

Evaluation of a canine Coll2-1 ELISA kit for use in equine serum and its correlation with radiographic joint disease.

Journal of equine veterinary science·2026
Same author

Erratum: Antimicrobial stewardship at a tertiary center in Portugal: insights from prescribers - ERRATUM.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

Severe Malaria Due to Plasmodium vivax With Pulmonary Involvement: A Case Report.

Cureus·2026
Same author

Risk Factor Control in a Portuguese Vascular Risk Clinic: A 16-Month Retrospective Cohort Study.

Cureus·2026

Related Experiment Video

Updated: May 23, 2025

Preparation of a Blood Culture Pellet for Rapid Bacterial Identification and Antibiotic Susceptibility Testing
11:25

Preparation of a Blood Culture Pellet for Rapid Bacterial Identification and Antibiotic Susceptibility Testing

Published on: October 15, 2014

35.5K

Managing Bacteremia: Insights Into Pathogen-Specific Treatment.

Mariana Salvado de Morais1, Ana Gonçalves2, Gonçalo Cristóvão2

  • 1Internal Medicine, Centro Hospitalar Universitário Lisboa Central, Lisbon, PRT.

Cureus
|March 10, 2025
PubMed
Summary

Recent bacteremia treatment advances favor shorter antibiotic courses and earlier oral switch. This review details evidence-based strategies for Gram-positive and Gram-negative infections, guiding clinical decisions.

Keywords:
bacteremiacoagulase-negative staphylococcienterobacteralesenterococcusgram-negative bacteremiagram-positive bacteremiamrsa bacteremiamssa bacteremiapseudomonas aeruginosastaphylococcus aureus

More Related Videos

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
08:30

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures

Published on: July 9, 2012

25.4K
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

449

Related Experiment Videos

Last Updated: May 23, 2025

Preparation of a Blood Culture Pellet for Rapid Bacterial Identification and Antibiotic Susceptibility Testing
11:25

Preparation of a Blood Culture Pellet for Rapid Bacterial Identification and Antibiotic Susceptibility Testing

Published on: October 15, 2014

35.5K
One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
08:30

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures

Published on: July 9, 2012

25.4K
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

449

Area of Science:

  • Infectious Diseases
  • Clinical Pharmacology
  • Antimicrobial Stewardship

Background:

  • Traditional bacteremia treatment involves prolonged intravenous antibiotics.
  • Recent evidence challenges these prolonged durations and IV-to-oral transition timing.
  • Optimizing antibiotic therapy for bacteremia is crucial for patient outcomes and antimicrobial stewardship.

Purpose of the Study:

  • To review recent evidence on bacteremia treatment duration.
  • To outline strategies for transitioning from intravenous to oral antibiotic therapy.
  • To provide guidance on managing Gram-positive and Gram-negative bacteremia.

Main Methods:

  • Narrative review of current scientific literature.
  • Integration of clinical guidelines and trial data.
  • Analysis of pathogen-specific considerations.

Main Results:

  • Evidence supports shorter antibiotic courses for uncomplicated bacteremia.
  • Defined criteria exist for transitioning to oral therapy.
  • Clinical decision-making frameworks are evolving.

Conclusions:

  • Shorter antibiotic durations are increasingly supported by evidence.
  • Judicious transition to oral therapy improves patient management.
  • Updated strategies are essential for effective bacteremia treatment.